The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
Xinwei Xu,1,* Jintu Huang,2,* Dickson Kofi Wiredu Ocansey,1,3 Yuxuan Xia,1 Zihan Zhao,1 Zhiwei Xu,1 Yongmin Yan,1 Xu Zhang,1 Fei Mao1 1Department of Clinical Laboratory Diagnostics, Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jia...
Saved in:
Main Authors: | Xu X (Author), Huang J (Author), Ocansey DKW (Author), Xia Y (Author), Zhao Z (Author), Xu Z (Author), Yan Y (Author), Zhang X (Author), Mao F (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease
by: Zhang Y, et al.
Published: (2021) -
The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
by: Dickson Kofi Wiredu Ocansey, et al.
Published: (2020) -
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
by: Mengjiao Zhou, et al.
Published: (2022) -
Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
by: Cao Y, et al.
Published: (2021) -
Research Progress of RNA Methylation Modification in Colorectal Cancer
by: Weizheng Liang, et al.
Published: (2022)